apl. Prof. Dr. Jürgen Rech

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasis (2020) Simon D, Haschka J, Muschitz C, Kocijan A, Baierl A, Kleyer A, Schett G, et al. Journal article Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis (2020) Birkner B, Rech J, Stargardt T Journal article Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits (2019) Ellmann H, Bayat S, Guilhon de Araujo E, Manger B, Kleyer A, Cavallaro A, Lell M, et al. Journal article Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs (2019) De Moel EC, Rech J, Mahler M, Roth J, Vogl T, Schouffoer A, Goekoop RJ, et al. Journal article The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study (2019) Häger J, Bang H, Hagen M, Frech M, Träger P, Sokolova MV, Steffen U, et al. Journal article Anti-citrullinated Vimentin Antibodies Are Associated to Early Deterioration of Cortical Bone and Volumetric Bone Mineral Density in Finger Joints in RA-at-risk Patients (2019) Schett G, Simon D, Hueber A, Bang H, Rech J, Krönke G, Kleyer A Conference contribution Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial (2019) Stone J, Spotswood H, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Long-Term Outcome of Tocilizumab for Patients with Giant Cell Arteritis: Results from Part 2 of a Randomized Controlled Phase 3 Trial (2019) Stone J, Bao M, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Maintained Benefit in Health-Related Quality of Life of Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone Tapering: Results from the Open-Label, Long-Term Extension of a Phase 3 Randomized Controlled Trial (2019) Stone J, Han J, Unizony S, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution Serum Calprotectin Is a Prognostic Marker for Drug-Free Remission in RA (2019) De Moel E, Rech J, Mahler M, Roth J, Schouffoer A, Ronday K, Huizinga T, et al. Conference contribution